-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cerebral small vessel disease (SVD) is considered a major factor in the pathogenesis of neurodegenerative diseases including Alzheimer's disease (AD)
Vascular Hypertension Prevention Although it is generally protective against infection and injury, a persistent inflammatory response can be detrimental to surrounding tissues
Managing Dementia (CAIDE) Score Cholesterol This paper aimed to investigate the relationship between midlife CAIDE score and SVD and inflammation in a cross-sectional manner
Nineteen cognitively healthy middle-aged participants, aged 40-59 years, were recruited
The CAIDE score was composed of weights for age, sex, education, systolic blood pressure, BMI, total cholesterol, physical activity, and APOE4 genotype (all variables measured at baseline)
WMH was scored visually on fluid-attenuated inversion recovery (FLAIR) MRI according to the Fazekas scale for calculating the SVD composite score
Higher CAIDE risk scores were cross-sectionally associated with greater SVD burden (WMH, CMB, lacunar, EPV, SVD composite score) and systemic inflammation (CRP, fibrinogen)
Higher CAIDE risk scores were cross-sectionally associated with greater SVD burden (WMH, CMB, lacunar, EPV, SVD composite score) and systemic inflammation (CRP, fibrinogen)
Link: Dementia risk prediction after 20 years (CAIDE score) in middle-aged people
Dementia risk prediction after 20 years (CAIDE score) in middle-aged adults LowA ,Prats-SedanoMA ,StefaniakJD LowA Low Prats-SedanoMA Prats-Sedano StefaniakJD Stefaniak , et al CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study Journal of Neurology, Neurosurgery & Psychiatry Published Online First: 08 February 2022.Published Online First: doi: 10.
1136/jnnp-2021-327462 doi:
Leave a comment here